← Leaderboards
Subhash C Gautam
Henry Ford Health System
$3,340,213
Attributed
$3,340,213
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $430.5K · FY2005–11$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$3,340,213 · 4
By mechanism
R01$1,797,083 · 2
P01$1,206,935 · 1
R21$336,195 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisBone Marrow TransplantationNonhuman Therapy EvaluationTumor Necrosis Factor AlphaNeoplasm /Cancer ChemotherapyPreventCell Proliferation2-Cyano-3,12-Dioxoolean-1,9-Dien-28-Oic AcidClinical TrialsCytolysinsAdverse EffectsAntineoplastic AgentsAnti-Bacterial AgentsAthymic MouseCell PhysiologyCombination TherapyCardiovascular Risk FactorAnti-InflammatoryAnti-Inflammatory AgentsAngiogenesisCardiovascular SystemAndrogensAntioxidantsAntigen Presentation
Grant awards (15)
Mechanisms of Triterpenoids in Prevention of Prostate Cancer$291,849
R01 · FY2011 · CA · contact PI
Mechanisms of Triterpenoids in Prevention of Prostate Cancer$300,875
R01 · FY2010 · CA · contact PI
Mechanisms of Triterpenoids in Prevention of Prostate Cancer$300,875
R01 · FY2009 · CA · contact PI
Mechanisms of Triterpenoids in Prevention of Prostate Cancer$300,875
R01 · FY2008 · CA · contact PI
Core--Outcome Measures and Cell Preparation$241,760
P01 · FY2007 · NS · contact PI
Core--Outcome Measures and Cell Preparation$249,085
P01 · FY2006 · NS · contact PI
Curcumin/TRAIL Combination Therapy of Prostae Cancer$181,395
R21 · FY2006 · CA · contact PI
Core--Outcome Measures and Cell Preparation$240,314
P01 · FY2005 · NS
Curcumin/TRAIL Combination Therapy of Prostate Cancer$154,800
R21 · FY2005 · CA
Core--Outcome Measures and Cell Preparation$236,925
P01 · FY2004 · NS
Cytokine Gene Therapy of Residual Leukemia$152,360
R01 · FY2004 · CA
Core--Outcome Measures and Cell Preparation$238,851
P01 · FY2003 · NS
Cytokine Gene Therapy of Residual Leukemia$151,199
R01 · FY2003 · CA
Cytokine Gene Therapy of Residual Leukemia$150,072
R01 · FY2002 · CA
Cytokine Gene Therapy of Residual Leukemia$148,978
R01 · FY2001 · CA